LV10458B - 4,13-dioxabicyclo£8.2.1.|tridecenone derivatives, method and intermediate products for preparation thereof and drugs containing that compounds - Google Patents

4,13-dioxabicyclo£8.2.1.|tridecenone derivatives, method and intermediate products for preparation thereof and drugs containing that compounds Download PDF

Info

Publication number
LV10458B
LV10458B LVP-93-01A LV930001A LV10458B LV 10458 B LV10458 B LV 10458B LV 930001 A LV930001 A LV 930001A LV 10458 B LV10458 B LV 10458B
Authority
LV
Latvia
Prior art keywords
formula
der
methyl
dioxabicyclo
die
Prior art date
Application number
LVP-93-01A
Other languages
English (en)
Latvian (lv)
Other versions
LV10458A (lv
Inventor
Hiltje Dagmar
Preuschoff Ulf
Eeckhout Christian
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of LV10458A publication Critical patent/LV10458A/xx
Publication of LV10458B publication Critical patent/LV10458B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
LVP-93-01A 1992-01-07 1993-01-06 4,13-dioxabicyclo£8.2.1.|tridecenone derivatives, method and intermediate products for preparation thereof and drugs containing that compounds LV10458B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4200145A DE4200145A1 (de) 1992-01-07 1992-01-07 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
LV10458A LV10458A (lv) 1995-02-20
LV10458B true LV10458B (en) 1996-02-20

Family

ID=6449136

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-01A LV10458B (en) 1992-01-07 1993-01-06 4,13-dioxabicyclo£8.2.1.|tridecenone derivatives, method and intermediate products for preparation thereof and drugs containing that compounds

Country Status (28)

Country Link
US (1) US5418224A (no)
EP (1) EP0550895B1 (no)
JP (1) JP3300084B2 (no)
KR (1) KR100273937B1 (no)
CN (1) CN1033646C (no)
AT (1) ATE155478T1 (no)
AU (1) AU667699B2 (no)
CA (1) CA2086811C (no)
CZ (1) CZ281773B6 (no)
DE (2) DE4200145A1 (no)
DK (1) DK0550895T3 (no)
DZ (1) DZ1652A1 (no)
ES (1) ES2104808T3 (no)
FI (1) FI106862B (no)
GR (1) GR3024859T3 (no)
HK (1) HK1014003A1 (no)
HU (2) HU212272B (no)
IL (1) IL104158A (no)
LT (1) LT3015B (no)
LV (1) LV10458B (no)
MX (1) MX9300045A (no)
NO (1) NO179586C (no)
PH (1) PH30098A (no)
RU (1) RU2107070C1 (no)
SK (1) SK279251B6 (no)
TW (1) TW238308B (no)
UA (1) UA29393C2 (no)
ZA (1) ZA9339B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69637097T2 (de) * 1995-10-13 2007-09-20 Neurosearch A/S 8-Azabicyclo(3.2.1)Oct-2-en-Derivate, deren Herstellung und Anwendung
EP0884322A4 (en) * 1996-03-01 2002-04-24 Takeda Chemical Industries Ltd PROCESS FOR THE PREPARATION OF ERYTHROMYCIN DERIVATIVES
US6077943A (en) * 1996-03-01 2000-06-20 Takeda Chemical Industries, Ltd. Method of producing erythromycin derivative
DE19644195A1 (de) * 1996-10-24 1998-04-30 Solvay Pharm Gmbh 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19805822B4 (de) * 1998-02-13 2009-02-05 Solvay Pharmaceuticals Gmbh 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US6165985A (en) * 1998-02-13 2000-12-26 Solvay Pharmaceuticals Gmbh 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them
CA2386828C (en) * 2000-08-17 2006-01-24 The Kitasato Institute Novel pseudoerythromycin derivatives
DE50204789D1 (de) * 2001-05-10 2005-12-08 Solvay Pharm Gmbh Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US20040067896A1 (en) * 2002-07-25 2004-04-08 The Kitasato Institute Novel pseudoerythromycin derivatives
JP4928261B2 (ja) 2003-06-18 2012-05-09 トランザイム・ファーマ・インコーポレイテッド モチリン受容体の大環状拮抗薬
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
BRPI0619556A2 (pt) * 2005-12-08 2011-10-04 Pfizer processo para desmetilação de grupo 3' -dimetil amino de compostos eritromicina
EP2431380A3 (en) 2006-09-11 2013-07-03 Tranzyme Pharma, Inc. Macrocyclic antagonist of the motilin receptor for treatment of gastrointestinal dysmotility disorders
BRPI0719565A2 (pt) * 2006-12-05 2013-12-10 Pfizer Polimorfos de motilídeo
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex
EP2979702A4 (en) * 2013-03-25 2016-11-16 Zeria Pharm Co Ltd POSTPRANDIAL GASTROKINETIC AGENT

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725385A (en) 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
CA1321581C (en) * 1987-05-26 1993-08-24 Herbert A. Kirst Ring-contracted macrolides
US5106961A (en) * 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
US4920102A (en) * 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders

Also Published As

Publication number Publication date
NO930029L (no) 1993-07-08
FI930051A0 (fi) 1993-01-07
AU667699B2 (en) 1996-04-04
CA2086811A1 (en) 1993-07-08
HU212272B (en) 1996-04-29
CN1075320A (zh) 1993-08-18
FI930051A (fi) 1993-07-08
ZA9339B (en) 1993-08-05
SK279251B6 (sk) 1998-08-05
PH30098A (en) 1996-12-27
EP0550895B1 (de) 1997-07-16
HUT66234A (en) 1994-10-28
DE59208710D1 (de) 1997-08-21
ES2104808T3 (es) 1997-10-16
SK341492A3 (en) 1995-05-10
IL104158A (en) 1997-07-13
CZ281773B6 (cs) 1997-01-15
NO179586C (no) 1996-11-06
NO930029D0 (no) 1993-01-06
KR930016436A (ko) 1993-08-26
JPH07247299A (ja) 1995-09-26
MX9300045A (es) 1993-12-01
LV10458A (lv) 1995-02-20
HK1014003A1 (en) 1999-09-17
LTIP187A (lt) 1994-03-25
CA2086811C (en) 2003-12-09
US5418224A (en) 1995-05-23
HU9204076D0 (en) 1993-04-28
DE4200145A1 (de) 1993-07-08
ATE155478T1 (de) 1997-08-15
RU2107070C1 (ru) 1998-03-20
AU3103693A (en) 1993-07-08
IL104158A0 (en) 1993-05-13
NO179586B (no) 1996-07-29
FI106862B (fi) 2001-04-30
UA29393C2 (uk) 2000-11-15
EP0550895A1 (de) 1993-07-14
HU210216A9 (en) 1995-02-28
LT3015B (lt) 1994-08-25
CZ341492A3 (en) 1993-07-14
CN1033646C (zh) 1996-12-25
KR100273937B1 (ko) 2000-12-15
TW238308B (no) 1995-01-11
DK0550895T3 (da) 1997-08-25
JP3300084B2 (ja) 2002-07-08
GR3024859T3 (en) 1998-01-30
DZ1652A1 (fr) 2002-02-17

Similar Documents

Publication Publication Date Title
DE3005164C2 (de) 1,1-Dioxopenicillanoyloxymethyl-6-(D-α-amino-α-phenylacetamido)-penicillanat, Verfahren zu seiner Herstellung und es enthaltendes Arzneimittel
LV10458B (en) 4,13-dioxabicyclo£8.2.1.|tridecenone derivatives, method and intermediate products for preparation thereof and drugs containing that compounds
DE3609052C2 (de) Anthracyclinglykoside, Verfahren zu ihrer Herstellung und sie enthaltende Zubereitungen
DE3500179C2 (no)
DD259858A5 (de) Verfahren zur herstellung von kristallinem torasemid der modifikation i
DE3318989C2 (de) ß,gamma-Dihydropolyprenylalkoholderivate und diese enthaltende Arzneimittel und deren Verwendung
DE60101476T2 (de) Stabiles gabapentin, das mehr als 20 ppm chlor enthält
EP0838469B1 (de) 10,13,15-Trioxatricyclo(9.2.1.1. 9.6)-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3443065C2 (no)
DE60017399T2 (de) Diphosphat-salz von einem 4"-substitutierte-9-deoxo-9a-aza-9a-homoerythromyin-derivat und seine pharmazeutische zubereitung
DE112004002032B4 (de) Concentricolid und seine Derivate, Verfahren zum Herstellen pharmazeutischer Zusammensetzungen umfassend deren Verwendung
DE2156637A1 (de) Purinzuckerderivate, Verfahren zu ihrer Herstellung und ihrer Verwendung
WO2013041182A1 (de) Kristallisierung von idarubicinhydrochlorid
DE2202690A1 (de) Verfahren zur Herstellung der Antibiotika 20798 RP und 27706 RP,sowie das Antibiotikum 27706 RP und Zusammensetzungen,die es enthalten
EP0065692A1 (de) Erythro-1,2,3-Triphenyl-1-pentanon-Derivate sowie Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2316705C3 (de) 9-Acyl -3' '-thiomethoxymethyl-SF-837-Macrolid-Antibiotika, Verfahren zur Herstellung derselben sowie diese enthaltende pharmazeutische Mittel
DE1620177C3 (de) N-(2-Hydroxyäthyl)-piperazinocarboxymethyl-tetracyclin, dessen pharmakologisch verwendbaren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0299910A2 (de) Metallhaltige Oligosaccharid-Polysulfate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel
EP0253293B1 (de) Neue Guanidiniumasparaginate
DE60115851T2 (de) Anti-infektionsmittel, die gegen gegenüber mehreren arzneimitteln resistente bakterienstämme nützlich sind
DE69910810T2 (de) Natriumsalz von 3-(4-cinnamyl-1-piperazinyl)-iminomethyl-rifamycin sv und verfahren zu seiner herstellung
DE1593015C3 (de) N.N'-Dimethyl-NJ'i'-di-detracyclinomethyl)-äthylendiamin und dessen Salze mit pharmakologisch unbedenklichen Mineral- und organischen Säuren sowie Verfahren zu deren Herstellung
DE2621615C3 (de) Dihydromocimycin, seine Salze, Verfahren zu seiner Herstellung und seine Verwendung als Futtermittelzusatz
DE2708666B2 (de) Arzneimittel mit immunoregulativer und antiphlogistischer Wirkung
DE3436625C2 (no)